FX Update: FX themes are muted and based on distant hopes FX Update: FX themes are muted and based on distant hopes FX Update: FX themes are muted and based on distant hopes

FX Update: FX themes are muted and based on distant hopes

Forex 5 minutes to read
John Hardy

Head of FX Strategy

Summary:  The market is positioning hopefully for a rapid roll-out of an effective vaccine, figuring that this will trigger a global reflationary boom, and figuring that a weakening US dollar will be a key contributor as a gridlocked US political system leaves only a very dovish Fed as the key actor in providing support for the recovery.

Today’s FX Trading focus:

Is the market trading too far forward?

There is very little new to add, as FX themes are very passive and could remain that way as long as we merely see strong risk sentiment together with a tamed long end of the US yield curve. For example, charting the EURUSD versus an intraday Nasdaq-100 future as I did in the slide deck of this morning’s Saxo Market Call podcast shows that it is difficult to tell the two apart over the last few weeks. The narrative is that we should all look forward to a reflationary boom on the other side of a successful Covid-19 vaccine rollout in coming months, with USD weakness powered by a very accommodative Fed, given the high odds of political gridlock in Washington. Even if the Democrats take the two Georgia run-off seats, the Democratic ability to bring stimulus will be somewhat constrained by centrist Democrats and especially the oddest Democrat of them all, West Virginia’s Joe Manchin.

We suspect the energy and themes in the market might change considerably if long US yields do head higher above 1.00% on the US 10-year and the reflationary narrative does eventually start to play out in the months ahead. On top of that is the question of how quickly the Fed would signal that. The US Treasury may have to issue well north of $2 trillion in net new treasuries next year to finance the government outlays, meaning that the current pace of Fed QE is insufficient. Given that much of US consumption ends up powering external deficits, this is part of the bearish long-term US dollar argument. On that note, Fed Vice Chair Clarida was out speaking yesterday and outlined that the Fed’s policy mix from here would rely heavily on expanding QE if necessary. Some, including the FT, decided that this speech likely included hints at changing the maturity of US treasury purchases, but there was nothing explicit in the speech pointing to that strategy yet, though I likewise see it as inevitable if US 10-year treasury yields pull to perhaps 1.25% or, at highest, 1.50%.

But we are getting ahead of ourselves and for now, it is tough to invest too much into the market narrative driving the US dollar lower in the very near term, when the drivers are based on very uncertainty events down the road (especially the timing portion of a successful vaccine roll-out). Besides the question of ongoing vaccine efficacy and distribution timing, we have to get a lame duck Trump concession, a pair of Georgia run-offs decided in early January (with possible Democratic control of the Senate at stake), and then the priorities of the incoming Biden presidency.

EURUSD is pushing at the topside once again, as the market waxes hopeful on global recovery down the road fueling demand for EU exports and a weaker US dollar on an accommodative Fed, but there is oh-so-much that could possibly go wrong and the reality on the ground in Europe is terrible at present, with the budget impasse the latest issue for Europe after Hungary and Poland vetoed the budget and recovery package over “rule of law” provisions they find unacceptable. (And despite the two countries benefitting the most, in net terms, from the new budget). What next there? In the meantime, have a hard time seeing EURUSD moving beyond 1.2000 until we see firmer evidence that EU is getting its house and economy in order amid a successful vaccine roll-out.

Source: Saxo Group

The G-10 rundown

USD – The US dollar on its back foot as the market prices an easy Fed and political gridlock. US Retail Sales today the US data release of the week.

EUR – not much to like here in broad euro terms (if EURUSD goes higher, would mostly likely be on USD weakness) as the EU remains a political mess for getting decisive action done and Covid-19 will rage away for months to come.

JPY – the yen firming a bit more as the rising US yield threat has backed away for now. The yen gets more interesting across the board if risk sentiment sours again, together with rates backing off lower.

GBP- sterling moving higher, perhaps as markets smell that UK Prime Minister Boris Johnson letting go of his more hard-line ideological advisers means he is ready to go soft on compromise with the EU to get a deal done?

CHF – the price action has gotten more interesting for upside interest in EURCHF, but we need global economic normalization to get interested in a CHF downtrend again.

AUD – If the future plays out as the market hopes, the AUD should prove a star-performer among the G10 in 2021 on a global reflation trade – tactically watching 0.7400+ as the next objective, having noted concerns on the quality of the near-term narrative elsewhere in today’s post.

CAD – the loonie looks better in a normalizing world with higher oil prices than it does at the moment – for upside interest, still need the USD breakthrough lower and 1.3000-1.2950 to fall in USDCAD.

NZD – the less dovish RBNZ was only good for a modest bump in NZD versus AUD – still see long term value in AUDNZD, but may be a strategic rather than a tactical trade – options, anyone?

SEK – the SEK strength is testament to how the market looks through the current reality on the ground, as the SEK only suffers minor turbulence on new covid-19 restrictions on a virus resurgence. If the market can continue to trade on hope rather than reality, 10.00 is possible in EURSEK, but a move above 10.30 suggests near term concern is nixing the krona upside potential for a while longer.

NOK – the recent EURNOK rally rejected at the 200-day moving average (near 10.87) and that resistance needs to hold as the market tries to trade in “fast-forward” mode on the world beyond Covid-19.

Upcoming Economic Calendar Highlights (all times GMT)

  • 1300 – Hungary Central Bank Rate Decision
  • 1315 – Canada Oct. Housing Starts
  • 1330 – US Oct. Retail Sales
  • 1400 – UK Bank of England Governor Bailey to Speak
  • 1415 – US Oct. Industrial Production and Capacity Utilization
  • 1500 – US Nov. NAHB Housing Market Index
  • 1600 – ECB President Lagarde to Speak
  • 1800 – US Fed Chair Powell to Speak
  • 1900 – Canada Bank of Canada’s Macklem to Speak
  • 2340 – Australia RBA’s Lowe to Speak
  • 1600 – UK BoE Governor Bailey to Speak

Saxo Capital Markets (Australia) Limited prepares and distributes information/research produced within the Saxo Bank Group for informational purposes only. In addition to the disclaimer below, if any general advice is provided, such advice does not take into account your individual objectives, financial situation or needs. You should consider the appropriateness of trading any financial instrument as trading can result in losses that exceed your initial investment. Please refer to our Analysis Disclaimer, and our Financial Services Guide and Product Disclosure Statement. All legal documentation and disclaimers can be found at https://www.home.saxo/en-au/legal/.

The Saxo Bank Group entities each provide execution-only service. Access and use of Saxo News & Research and any Saxo Bank Group website are subject to (i) the Terms of Use; (ii) the full Disclaimer; and (iii) the Risk Warning in addition (where relevant) to the terms governing the use of the website of a member of the Saxo Bank Group.

Saxo News & Research is provided for informational purposes, does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. No Saxo Bank Group entity shall be liable for any losses that you may sustain as a result of any investment decision made in reliance on information on Saxo News & Research.

To the extent that any content is construed as investment research, such content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication.

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments.Saxo Capital Markets does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo Capital Markets or its affiliates.

Please read our disclaimers:
- Full Disclaimer (https://www.home.saxo/en-au/legal/disclaimer/saxo-disclaimer)
- Analysis Disclaimer (https://www.home.saxo/en-au/legal/analysis-disclaimer/saxo-analysis-disclaimer)
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)

Saxo Capital Markets (Australia) Limited
Suite 1, Level 14, 9 Castlereagh St
Sydney NSW 2000

Contact Saxo

Select region


The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-au/about-us/awards

Saxo Capital Markets (Australia) Limited ABN 32 110 128 286 AFSL 280372 (‘Saxo’ or ‘Saxo Capital Markets’) is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms, Financial Services Guide, Product Disclosure Statement and Target Market Determination to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Saxo Capital Markets does not provide ‘personal’ financial product advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Capital Markets does not take into account an individual’s needs, objectives or financial situation. The Target Market Determination should assist you in determining whether any of the products or services we offer are likely to be consistent with your objectives, financial situation and needs.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website is not intended for residents of the United States and Japan.

Please click here to view our full disclaimer.